Physician profile
Benjamin George Roach
NPI 1124541719
$10,157.65
in general payments reported to CMS, 2019-2025
35 companies · $1,850 in 2025
The $1,850 reported for 2025 was more than what 96% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,704 · 2020: $684 · 2021: $1,184 · 2022: $1,166 · 2023: $1,926 · 2024: $1,643 · 2025: $1,850.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,308 · Entertainment: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,307.85 |
| Entertainment | $111.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,216.55 | 2022-2025 | Durysta, Vuity, Alphagan P |
| Sun Pharmaceutical Industries INC. | $1,010.14 | 2019-2025 | Cequa |
| Allergan, INC. | $950.47 | 2019-2022 | |
| Alcon Vision LLC | $641.29 | 2022-2025 | Clareon, Total30, Clareon Panoptix Pro |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $578.94 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $577.97 | 2022-2025 | Xiidra, Miebo, Infuse |
| Glaukos Corporation | $559.42 | 2019-2025 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Idose, Idosetr |
| Biotissue Holdings INC. | $522.48 | 2023-2025 | |
| Eyevance Pharmaceuticals LLC | $518.19 | 2019-2021 | |
| Coopervision INC. | $516.40 | 2022-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $373.77 | 2020-2023 | Tecnis Iol |
| Novartis Pharmaceuticals Corporation | $344.63 | 2019-2023 | |
| Johnson & Johnson Vision Care, INC. | $331.01 | 2022-2024 | Acuvue |
| Aerie Pharmaceuticals, INC. | $244.68 | 2019-2021 | |
| Oyster Point Pharma, INC. | $237.44 | 2022-2025 | Tyrvaya |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $189.42 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $185.47 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $184.98 | 2021-2025 | Oxervate |
| Rxsight INC | $182.73 | 2023-2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Harrow Eye, LLC | $181.80 | 2025 | Vevye |
| Kala Pharmaceuticals, INC. | $120.12 | 2019-2020 | |
| Optos, INC. | $111.99 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Regeneron Healthcare Solutions, INC. | $72.24 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $63.67 | 2020-2021 | |
| Thea Pharma INC. | $55.30 | 2023-2025 | Iyuzeh |
| Sight Sciences, INC. | $37.58 | 2019-2020 | |
| Horizon Therapeutics Plc | $24.61 | 2021 | |
| Genmab U.S., INC. | $22.49 | 2023 | Tivdak |
| Astellas Pharma US INC | $18.88 | 2024 | Izervay |
| Amgen INC. | $15.98 | 2024 | Tepezza |
| Alimera Sciences, INC. | $15.78 | 2021 | |
| Mallinckrodt Enterprises LLC | $15.74 | 2019 | |
| Omeros Corporation | $14.51 | 2020 | |
| Staar Surgical Company | $14.36 | 2019 | |
| New World Medical,INC. | $6.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Roach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.